Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
01/2004
01/21/2004EP0811002B1 Benzylpiperidines and piperazines as muscarinic antagonists
01/21/2004CN1469866A New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication
01/21/2004CN1469862A 2,2-diphenyl butanamide derivatives and medicines containing the same
01/21/2004CN1469860A Aza-amino acid derivatives (factor XA-inhibitors 15)
01/21/2004CN1135229C Water soluble azoles as broad-spectrum antifungals
01/20/2004US6680321 4-((1-piperazinylmethyl)-benzamide derivatives; hypotensive agents; immunomodulators
01/20/2004US6680320 Urokinase inhibitors
01/20/2004US6680317 N-(phenyl)-n*-(2-hydroxy-3-aminosulfonylphenyl)guanidine derivatives; chemokine inhibitors; respiratory, cardiovascular, rheumatic, brain, and nervous system disorders
01/20/2004CA2243404C Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
01/17/2004CA2435399A1 New anthracene derivatives and their use as pharmaceutical preparations
01/15/2004WO2004005513A2 Methods for specifically inhibiting histone deacetylase-7 and 8
01/15/2004WO2004005278A1 Bisarylsulfonamide compounds and their use in cancer therapy
01/15/2004WO2004005229A1 Modulators of the glucocorticoid receptor
01/15/2004WO2004004648A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
01/15/2004WO2003091247A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
01/15/2004US20040010149 Ligand for transition metal complex catalyst
01/15/2004US20040010106 Monomer compound comprising several cationic groups, process for making the same, and polymers comprising units deriving therefrom
01/15/2004US20040010037 Cyanophenyl derivative
01/15/2004US20040009994 Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions
01/15/2004US20040009987 4-phenylpiperidinyl- or 4-phenylpiperazinyl-; including N-oxides
01/15/2004US20040009985 Bicyclo 4.4.0 antiviral derivatives
01/15/2004US20040009982 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
01/15/2004US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity
01/15/2004US20040009923 Alpha-substituted methyl ketones derived from aspartic acid and the closed hemi-ketal forms thereof
01/15/2004CA2491994A1 Modulators of the glucocorticoid receptor
01/15/2004CA2491127A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
01/15/2004CA2490579A1 Methods for specifically inhibiting histone deacetylase-7 and 8
01/15/2004CA2488816A1 Bisarylsulfonamide compounds and their use in cancer therapy
01/14/2004EP1380569A1 Ionic liquid, electrolyte salt for storage device, electrolytic solution for storage device, electric double layer capacitor, and secondary battery
01/14/2004EP1380562A1 Carboxylic acid derivative and salt thereof
01/14/2004EP1380306A1 Remedies for psychoneurosis
01/14/2004EP1379515A1 Lipid lowering biphenylcarboxamides
01/14/2004EP1379509A1 A method for the preparation of oxazolidinones
01/14/2004EP1379498A1 Sulphones which modulate the action of gamma secretase
01/14/2004EP1379496A1 Sulphones which modulate the action of gamma secretase
01/14/2004EP1379493A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
01/14/2004EP1379234A1 Halogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf
01/14/2004EP1212292B1 (-)-verbenone derivatives
01/14/2004EP1147098B1 Compounds comprising acrylate and cyclic sec.-amine functionalities
01/14/2004CN1468227A Non-imidazole aryloxyalkylamines
01/14/2004CN1468221A Non-imidazole aryloxypiperidines
01/14/2004CN1468214A Novel derivatives of aminocyclohexane
01/14/2004CN1468207A New retinoids for the treatment of emphysema
01/14/2004CN1468113A Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
01/14/2004CN1134457C New alpha-aminoacetophenone photoinitiators
01/14/2004CN1134414C Substituted oximes, hydrazones and olefins as neurokinin antagonists
01/14/2004CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same
01/14/2004CN1134410C Amine derivative, process for producing same, and use thereof as antiarrhythmic medicine
01/13/2004US6677486 Hydrogenating nitrites to primary amines over an activated, alpha-aluminum oxide(al2o3)-containing, macroporous raney catalyst based on an alloy of aluminum and at least one transition metal
01/13/2004US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents
01/13/2004US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis
01/13/2004US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
01/13/2004US6677378 Monoamine reuptake inhibitors for treatment of CNS disorders
01/13/2004US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677367 Lysine derivative with 2-aminosulfonylthiophene substituent; acquired immunodeficiency syndrome (aids) viricides
01/13/2004US6677360 Biphenyl and biphenyl-analogous compounds as integrin antagonists
01/13/2004US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677343 Substituted piperazine compounds
01/13/2004US6677336 Substituted piperazine compounds
01/13/2004US6677308 Integrin antagonists; antitumor, antimetastasis, anticarcinogenic agents; angiogenesis and restenosis inhibitors; osteoporosis
01/13/2004US6676928 Perfluoroalkyl-containing complexes with polar radicals, process for their production and their use
01/13/2004US6676926 Radiopharmaceuticals for diagnosing Alzheimer's disease
01/08/2004WO2004002965A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
01/08/2004WO2004002944A1 Inhibitors of hcv ns5b polymerase
01/08/2004WO2004002940A1 Inhibitors of hcv ns5b polymerase
01/08/2004WO2004002939A2 Aminoalcohol derivatives
01/08/2004WO2004002491A1 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors
01/08/2004WO2003064378A3 Novel compounds that inhibit factor xa activity
01/08/2004WO2003047515A3 P2x7 receptor antagonists
01/08/2004US20040006238 As chemical intermediates for production of pharmacologically useful oxazolidinones
01/08/2004US20040006236 Diaminopropionic acid derivatives
01/08/2004US20040006143 Aminoalcohol derivatives
01/08/2004US20040006141 Amidocarboxylic acid compounds
01/08/2004US20040006134 Antiandrogenic biphenyls
01/08/2004US20040006080 Chemical compounds
01/08/2004US20040006061 Suitable for the antimicrobial treatment of surfaces, as antimicrobial active substances against gram-positive and gram-negative bacteria
01/08/2004US20040006049 For therapy of prostatitis, benign prostate hyperplasia or prostate cancer
01/08/2004CA2492065A1 Aminoalcohol derivatives_as b3 adrenergic receptor agonist
01/08/2004CA2491156A1 Inhibitors of hcv ns5b polymerase
01/08/2004CA2490950A1 Inhibitors of hcv ns5b polymerase
01/08/2004CA2488525A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors
01/07/2004EP1378230A1 Para-phenylenediamine derivatives comprising a pyrrolidinyl group substituted by a cyclic radical and their use in colouring keratinic fibres
01/07/2004EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer
01/07/2004EP1377571A1 Compounds for use in the treatment of skin conditions
01/07/2004EP1377542A1 Hiv protease inhibitors based on amino acid derivatives
01/07/2004EP1377536A1 Self-reducing anthraquinone compounds
01/07/2004EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
01/07/2004EP1377282A2 Aryl-n-cyanoguanidines and methods related thereto
01/07/2004EP1056733B1 Histamine h3 receptor ligands
01/07/2004EP0944611B1 Dimesylate salts of neuropeptide y ligands
01/07/2004CN1466569A Novel 3-substituted urea derivatives and medicinal use thereof
01/07/2004CN1133618C Method for prodn. of amino ethyl-hydramine and/or ethylol piperazine
01/06/2004US6673850 Odorless photoinitiator compounds having chain transfer groups
01/06/2004US6673799 Inhibits binding to androgen receptor; antiandrogen
01/06/2004CA2253870C Inhibition of matrix metalloproteases by substituted phenalkyl compounds
01/06/2004CA2145248C Pharmaceutical compositions containing time-released orally taken trimetazidine
01/02/2004EP1375476A1 A new process for the synthesis of alkoxyamines active in controlled radical polymerization
01/02/2004EP1375457A1 One-pot process for the preparation of functionalized alkoxyamines
01/02/2004EP1374868A1 Remedies and/or preventives for diabetic ischemic heart diseases
01/02/2004EP1373234A2 Urokinase inhibitors